• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Syngene International Limited — Updates, 19-01-2026: Press Release

    19-01-2026 | 09:30 am

    Syngene International extended its long-term research collaboration with Bristol Myers Squibb until 2035. This broadens integrated drug development services, reinforcing Syngene's strategic partner role and ensuring stable, long-term business growth.

    No comments yet. Be the first to comment!

    All announcements from Syngene International Limited